Meconium Aspiration Syndrome (MAS)

Neonatal Disease

Complete post test after you read this module. Save your certificate of completion!

 Meconium Aspiration Syndrome (MAS)

Overview

 Meconium aspiration syndrome (MAS) is a respiratory disorder that occurs in newborns when they inhale meconium-stained amniotic fluid, leading to airway obstruction and potential lung injury. Meconium is the earliest stool of a newborn, and aspiration refers to the inhalation of this thick, greenish material into the lungs. 

 

1. Causes:

The passage of meconium into the amniotic fluid can occur due to fetal distress,

which might be caused by factors such as hypoxia (inadequate oxygen supply)

or other complications during labor. When the baby takes its first breaths, meconium

can be aspirated into the airways. 

 

2. Pathophysiology:

Meconium is a viscous substance that can block the airways and interfere with normal lung function. It may also cause chemical irritation and inflammation in the lungs, leading to a condition known as chemical pneumonitis. Additionally, meconium can mix with surfactant in the lungs, further contributing to respiratory distress. 

 

3. Clinical Presentation:

Newborns with MAS may exhibit the following signs and symptoms: 

  • Respiratory Distress: Rapid or labored breathing, grunting, or retractions (visible sinking of the chest between the ribs and under the breastbone during breathing). 

  • Cyanosis: Bluish discoloration of the skin, especially around the lips and nail beds, due to inadequate oxygenation. 

  • Decreased Breath Sounds: Meconium can block the airways, leading to decreased breath sounds upon auscultation. 

  • Barrel-Shaped Chest: Increased work of breathing can cause the chest to appear barrel-shaped. 

  • Lethargy or Poor Muscle Tone: The baby may appear weak or have decreased muscle tone. 

 

4. Diagnostic Evaluation:

The diagnosis of MAS is based on clinical presentation, especially in infants born through meconium-stained amniotic fluid. Chest X-rays may reveal hyperinflation, patchy atelectasis (collapsed lung tissue), and streaky or patchy infiltrates. 

 

  

 

5. Management: The management of MAS involves supportive care to help the infant breathe and ensure adequate oxygenation. Treatment options include: 

  • Respiratory Support: Mechanical ventilation or continuous positive airway pressure (CPAP) may be necessary to assist with breathing. 

  • Oxygen Therapy: Supplemental oxygen is provided to maintain appropriate oxygen levels in the blood. 

  • Suctioning: Suctioning of the airways may be performed to remove meconium and facilitate breathing. 

  • Surfactant Replacement Therapy: In severe cases, surfactant replacement may be considered to improve lung function. 

  • Antibiotics: If there is a risk of infection due to meconium aspiration, antibiotics may be administered. 

 

6. Prognosis:

The prognosis for infants with MAS varies. Mild cases may resolve with supportive care, while severe cases can lead to complications such as pneumonia or persistent pulmonary hypertension of the newborn (PPHN). Long-term outcomes depend on the extent of lung injury. 

 

7. Prevention:

Respiratory Therapists (RTs) in the Neonatal Intensive Care Unit (NICU) play a crucial role in managing and preventing complications such as Meconium Aspiration Syndrome (MAS). Here are some scientific approaches that NICU RTs can take to help prevent MAS: 

 

Antenatal Steroids: 

  • Administering antenatal steroids to pregnant women at risk of preterm delivery is a preventive measure. 

  • Steroids enhance lung maturation in the fetus, reducing the risk of respiratory distress, including MAS. 

    Continuous Fetal Monitoring: 

  • RTs can work collaboratively with the healthcare team to monitor fetal well-being during labor continuously. 

  • Timely detection of fetal distress allows for interventions to prevent further complications, including meconium aspiration. 

    Intrapartum Monitoring and Intervention: 

  • Monitoring the baby's heart rate during labor can indicate fetal distress. 

  • Swift intervention, such as the use of forceps or vacuum extraction, can reduce the likelihood of meconium release into the amniotic fluid. 

    Endotracheal Suctioning: 

  • NICU RTs should be prepared to perform endotracheal suctioning immediately after delivery. 

  • Suctioning helps clear the airways of meconium, preventing its aspiration into the lungs. 

    Resuscitation Techniques: 

  • Utilizing appropriate resuscitation techniques, such as positive pressure ventilation, helps initiate

    effective breathing in the newborn. 

  • This reduces the risk of meconium entering the respiratory passages during the first breaths. 

    Surfactant Administration: 

  • In cases where MAS is anticipated or confirmed, RTs may be involved in the administration of exogenous surfactant. 

  • Surfactant replacement therapy can improve lung compliance and prevent atelectasis, reducing the severity of MAS. 

    Oxygen Therapy Management: 

  • RTs play a critical role in managing oxygen therapy to prevent hypoxia and minimize the risk of meconium-related complications. 

  • Monitoring oxygen saturation levels and adjusting oxygen delivery accordingly is essential. 

Why is important for an RT to be ready when a baby has meconium aspiration?

When attending a delivery complicated by meconium aspiration, respiratory therapists (RTs) must be prepared to provide immediate and targeted respiratory support. Many of these babies suffer from respiratory depression so we must be ready to give PPV. This includes ensuring the availability of equipment for suctioning the airway. We must remember, routine intubation and suctioning of the trachea is no longer indicated by NRP. This can still be performed if the RT thinks oxygenation or ventilation is being compromised by the meconium. Continuous monitoring of oxygen saturation (target SpO₂: 90–95%) and respiratory rate (normal: 40–60 breaths per minute) is essential. The RT should be ready to assist with advanced airway management, such as intubation and mechanical ventilation, in cases of significant respiratory distress or failure. Management may also involve surfactant therapy for severe respiratory compromise, oxygen therapy, and monitoring for potential complications like pneumothorax and persistent pulmonary hypertension of the newborn (PPHN). Early coordination with the NICU team is vital for comprehensive care.